Research and Development

Showing 15 posts of 9599 posts found.

Pfizer’s new RA treatment shows promise

November 11, 2009 Research and Development, Sales and Marketing Pfizer, RA

 Pfizer has announced data from two clinical studies of its developmental rheumatoid arthritis candidate.CP-690550 is the first in a new …

Quintiles gets bigger in Singapore

November 10, 2009 Research and Development CRO

Contract research organisation Quintiles is planning to expand its workforce in Singapore to more than 500 employees "to accommodate increased …

Newly-merged Pfizer unveils streamlined R&D operations

November 10, 2009 Research and Development Pfizer, restructure

 Pfizer is to close six research sites in the US and two in the UK to create its new streamlined …

Cambrex sales rise in Q3 despite ‘challenging environment’

November 9, 2009 Manufacturing and Production, Research and Development CMO, CRO

Contract development and manufacturing services firm Cambrex saw its sales advance 2% to $58 million in the third quarter on …

Novartis gets German OK for swine flu vaccine

November 5, 2009 Research and Development, Sales and Marketing Novartis, h1n1

 Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …
Actelion Robin

Actelion UK appoints Robin Bhattacherjee General Manager

November 4, 2009 Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing

Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

Dr John Nash, Senior Director ADME/PK, BioFocus

November 3, 2009 Research and Development appointment, biofocus, research and development

BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK.  John has …

Phase III success for GSK’s lupus drug

November 3, 2009 Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …

Whatever happened to yesterday’s ‘magic bullets’?

November 3, 2009 Research and Development Les Rose, biotech

How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …

Fast times at contract research firm PPD

November 3, 2009 Research and Development CRO

Pharmaceutical Product Development (PPD) has unveiled several new initiatives to re-inject some growth momentum into the business as its third-quarter …

GSK-Genmab blood cancer drug approved in US

November 2, 2009 Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009 Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …

GSK begins phase III COPD trials

October 28, 2009 Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
The Gateway to Local Adoption Series

Latest content